Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Outcomes of Autologous Stem Cell Transplant in Primary and Secondary Central Nervous System Lymphoma - a Multi Center Experience in Singapore

Blood (2024) 144 (Supplement 1): 6467.

https://doi.org/10.1182/blood-2024-205120

Published: 2024

Journal Articles

Haploidentical Transplant Using Selective Ex-vivo TCR-Αβ Depleted and Upfront Memory T-Cell Add-Back Is Associated with Lower Chronic Gvhd and More Favorable Gvhd-Free/Relapse-Free Survival As Compared to Matched Related and Unrelated Donor Transplant for Adults with Hematological Malignancies

Blood (2024) 144 (Supplement 1): 3529.

https://doi.org/10.1182/blood-2024-200952

Published: 2024

Journal Articles

Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore

Natasha Fay Anthony, Yen-Lin Chee, Pak Ling Lui, Esther Chan, Michelle Poon, Lip Kun Tan, Jameelah Binte Sekh Mohamed, Liang Piu Koh, Melissa G OOI, Wee-Joo Chng, Wei-Ying Jen

Blood (2024) 144 (Supplement 1): 7899.

https://doi.org/10.1182/blood-2024-198845

Published: 2024

Journal Articles

Letermovir Primary Prophylaxis in Preventing Cytomegalovirus (CMV) Reactivation in Ex-Vivo Tcrαβ-Depleted Haploidentical Allogeneic Haematopoietic Cell Transplantation with Memory T Cell Add-Back

Ao Ran Boo, Yi Ching Yuen, Chin Menn Woon, Michelle Poon, Lip Kun Tan, Joanne Shu Xian Lee, Victor Ling, Yeh Ching Linn, Hein Than, Zi YI LIM, Colin Phipps Diong, Liang Piu Koh

Blood (2024) 144 (Supplement 1): 7279.

https://doi.org/10.1182/blood-2024-200139

Published: 2024

Journal Articles

Efficacy and Safety of Epcoritamab Monotherapy in Patients with Relapsed or Refractory LBCL Not Previously Exposed to CAR T: Subanalysis of the Epcore NHL-1 Trial

Yasmin H. Karimi, Michael Roost Clausen, David John Lewis, Wojciech Jurczak, Michelle Poon, Tae Min Kim, Young Rok Do, Pieternella Lugtenburg, Kristin Conte, David Soong, Barbara D'Angelo Månsson, Zhu Li, Christian Eskelund, Martin Hutchings

Blood (2024) 144 (Supplement 1): 1737.

https://doi.org/10.1182/blood-2024-199225

Published: 2024

Journal Articles

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma

Blood (2024) 143 (2): 152–165.

https://doi.org/10.1182/blood.2023021348

Published: 2024

Includes: Supplemental data

Journal Articles

Development of a Novel Artificial Intelligence Tool to Measure Psoas Volumes in Patients with Diffuse Large B Cell Lymphoma

Edwin Wei Sheng Thong, Andrew Makmur, Yen-Lin Chee, James Hallihan, Lenith Tai Jit Cheng, Nesaretnam Barr Kumarakulasinghe, Anand Devaprasath Jeyasekharan, Joanne Shu Xian Lee, Sanjay De Mel, Esther Hian Li Chan, Michelle Poon, Wee-Joo Chng, Jayalakshmi ., Melati Dewi Ali, Wei-Ying Jen, Desmond Shi Wei Lim

Blood (2023) 142 (Supplement 1): 3652.

https://doi.org/10.1182/blood-2023-178239

Published: 2023

Journal Articles

Results of a Second, Prespecified Analysis of the Phase 2 Study ELM-2 Confirm High Rates of Durable Complete Response with Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) with Extended Follow-up

Blood (2023) 142 (Supplement 1): 3041.

https://doi.org/10.1182/blood-2023-181650

Published: 2023

Journal Articles

An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators

Catherine Tang, Lucy Zhang, Adam Suleman, Katharine L. Lewis, Daire Quinn, Michelle Poon, William Hann, Edward Pringle, Svetlana Cherepanoff, Luke Coyle, Shireen Kassam, Pam McKay, Chan Yoon Cheah, Anca Prica, Jeffery Smith, Nada Hamad

Blood (2023) 142 (Supplement 1): 3132.

https://doi.org/10.1182/blood-2023-178431

Published: 2023

Journal Articles

Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study

Blood (2023) 142 (Supplement 1): 4504.

https://doi.org/10.1182/blood-2023-180743

Published: 2023

Journal Articles

Maintenance of Moderate to High Levels of Functioning and Quality of Life with Odronextamab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 669.

https://doi.org/10.1182/blood-2023-181942

Published: 2023

Journal Articles

Survival Outcomes, Efficacy and Tolerability of a Pediatric-Inspired Regimen (MASPORE) for Philadelphia-Negative Acute Lymphoblastic Leukemia in Young Adults at a Tertiary Hospital in Singapore

Victor Ling Wei Teik, Sai Lon Wann, Jing Yuan Tan, Jameelah Sheik Mohamed, Wei Ying Jen, Pak Ling Lui, Michelle Poon, Esther Hian Li Chan, Liang Piu Koh, Lip Kun Tan, Chin Hin Ng, Allen Eng Juh Yeoh, Melissa Ooi

Blood (2023) 142 (Supplement 1): 5881.

https://doi.org/10.1182/blood-2023-189139

Published: 2023

Journal Articles

Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Blood (2023) 142 (Supplement 1): 436.

https://doi.org/10.1182/blood-2023-179818

Published: 2023

Journal Articles

Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell–treated patients

Bernice Ling Zhi Oh, Nicole Tan, Ruklanthi de Alwis, Kamini Kunasegaran, Zhiwei Chen, Michelle Poon, Esther Chan, Jenny G. H. Low, Allen Eng Juh Yeoh, Antonio Bertoletti, Nina Le Bert

Blood (2022) 140 (2): 156–160.

https://doi.org/10.1182/blood.2022016166

Published: 2022

Includes: Supplemental data

Journal Articles

Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)

Blood (2021) 138 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2021-145959

Published: 2021

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back in Adults and Children with Hematological Malignancies: 4-Year Follow-up of Multicenter Study in Singapore

Ian Q Wu, Yeh Ching Linn, Yang Liang Boo, Rajat Bhattacharyya, Zi Yi Lim, Michelle Poon, Michaela Su-Fern Seng, Poh Lin Tan, Colin Phipps, Balamurugan Vellayappan, Ah Moy Tan, Lip Kun Tan, Yvonne Su Ming Loh, Teck Guan Soh, Gina Gan, Yin Jie Koh, Wing H. Leung, Liang Piu Koh

Blood (2021) 138 (Supplement 1): 555.

https://doi.org/10.1182/blood-2021-152372

Published: 2021

Journal Articles

Graft-Vs-Host Disease (GvHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCy) and Thymoglobulin (ATG) Are More Important Determinants of Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Cell Transplantation (HCT) Than Ex-Vivo T-Cell Depletion in the Era of Pre-Emptive Therapy

Lip Leong Chong, Chelsea Chia, Yin Teng Koh, Yang Liang Boo, Chun Tsu Lee, Michelle Poon, Lip Kun Tan, Liang Piu Koh

Blood (2021) 138 (Supplement 1): 2859.

https://doi.org/10.1182/blood-2021-152689

Published: 2021

Journal Articles

Validation and Implementation of the Use of Peripherally Inserted Central Catheter (PICC) for the Administration of Peripheral Blood Stem Cells (PBSC): A Single-Institution Experience

Sai Lon Wann, Shi Hui Clarice Choong, Teck Guan Soh, Foong Gwan Lee, Yee Mei Lee, Jedidah Lieow, Yelly Yelly, Sharmila Kasinathan, Chue Teng Chua, Kwee Cheng Chia, Belinda Tan, Hui Li Lim, Eric Soong Wen Jian, Davanaliz Gonzales Ramos, Joanne Lee, Lip Kun Tan, Liang Piu Koh, Michelle Poon, Eng Soo Yap

Blood (2021) 138 (Supplement 1): 4032.

https://doi.org/10.1182/blood-2021-151925

Published: 2021

Journal Articles

Clinical Outcomes of Adults and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): A Multicenter Analysis of Pediatric-Inspired Protocol (MASPORE) Vs Hyper-CVAD in Singapore

Sai Lon Wann, Tertius Tuy, Victor Ling Wei Teik, Christian Gallardo, Lip Leong Chong, Samuel Sherng Young Wang, Nurul Aidah Abdul Halim, Yar Myint Zay, Allen Eng Juh Yeoh, Sampath Venkata Sreekanth, Chin Hin Ng, Michelle Poon, Gee Chuan Wong, Melissa Ooi

Blood (2021) 138 (Supplement 1): 1238.

https://doi.org/10.1182/blood-2021-150615

Published: 2021

Journal Articles

Ambiguous Diagnosis of Nodal T-Cell Lymphomas with T-Follicular Helper (TFH) Phenotype and Hodgkin Lymphoma - a Multicenter Pilot Study

Blood (2021) 138 (Supplement 1): 1403.

https://doi.org/10.1182/blood-2021-149358

Published: 2021

NARROW

Outcomes of Autologous Stem Cell Transplant in Primary and Secondary Central Nervous System Lymphoma - a Multi Center Experience in Singapore

Haploidentical Transplant Using Selective Ex-vivo TCR-Αβ Depleted and Upfront Memory T-Cell Add-Back Is Associated with Lower Chronic Gvhd and More Favorable Gvhd-Free/Relapse-Free Survival As Compared to Matched Related and Unrelated Donor Transplant for Adults with Hematological Malignancies

Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore

Letermovir Primary Prophylaxis in Preventing Cytomegalovirus (CMV) Reactivation in Ex-Vivo Tcrαβ-Depleted Haploidentical Allogeneic Haematopoietic Cell Transplantation with Memory T Cell Add-Back

Efficacy and Safety of Epcoritamab Monotherapy in Patients with Relapsed or Refractory LBCL Not Previously Exposed to CAR T: Subanalysis of the Epcore NHL-1 Trial

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma

Development of a Novel Artificial Intelligence Tool to Measure Psoas Volumes in Patients with Diffuse Large B Cell Lymphoma

Results of a Second, Prespecified Analysis of the Phase 2 Study ELM-2 Confirm High Rates of Durable Complete Response with Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) with Extended Follow-up

An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators

Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study

Maintenance of Moderate to High Levels of Functioning and Quality of Life with Odronextamab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

Survival Outcomes, Efficacy and Tolerability of a Pediatric-Inspired Regimen (MASPORE) for Philadelphia-Negative Acute Lymphoblastic Leukemia in Young Adults at a Tertiary Hospital in Singapore

Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell–treated patients

Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)

HLA-Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back in Adults and Children with Hematological Malignancies: 4-Year Follow-up of Multicenter Study in Singapore

Validation and Implementation of the Use of Peripherally Inserted Central Catheter (PICC) for the Administration of Peripheral Blood Stem Cells (PBSC): A Single-Institution Experience

Clinical Outcomes of Adults and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): A Multicenter Analysis of Pediatric-Inspired Protocol (MASPORE) Vs Hyper-CVAD in Singapore

Ambiguous Diagnosis of Nodal T-Cell Lymphomas with T-Follicular Helper (TFH) Phenotype and Hodgkin Lymphoma - a Multicenter Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only